Bullous pemphigoid

Indian Journal of Dermatology, Venereology and Leprology

Volumn 77, Issue 4, 2011, Pages 450-455

  Khandpur, Sujay ^a   Verma, Parul ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bullous pemphigoid; clinical features; India; management

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BETAMETHASONE; CAPTOPRIL; CLOBETASOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; DEXAMETHASONE; FUROSEMIDE; IBUPROFEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHOXSALEN; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PENICILLAMINE; PHENACETIN; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; TETRACYCLINE; TIBOLONE;

AGED; BLISTER; BULLOUS PEMPHIGOID; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE COMPARISON; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INDIA; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; PRURITUS; SKIN DEFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; WESTERN BLOTTING;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDIA; PEMPHIGOID, BULLOUS;

EID: 79960275875     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.82398     Document Type: Conference Paper

References (42)

1. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: Population based cohort study. BMJ 2008;337:a180.
2. Sharma R, Nadeem M, Chandra M. Bullous pemphigoid in childhood. Indian J Dermatol Venereol Leprol 1996;62:100-2. (Pubitemid 126146764)
3. Leuci S, Grcan HM, Ahmed AR. Serological Studies in Bullous Pemphigoid: A Literature Review of Antibody Titers at Presentation and in Clinical Remission. Acta Derm Venereol 2010;90:115-21.
4. Ujiie H, Shibaki A, Nishie W, Shimizu H. What's new in bullous pemphigoid. J Dermatol 2010;37:3194-204.
5. Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, et al. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 2008;144:41-8. (Pubitemid 351159388)
6. Balachandran C, Rai VM. Localised bullous pemphigoid in the breast. Indian J Dermatol Venereol Leprol 2006;72:158-9.
7. Mehta V, Balachandran C. Localized flexural bullous pemphigoid. Indian J Dermatol 2008;53:157-8.
8. Korman NJ, Woods SG. Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol 1995;133:967-71. (Pubitemid 26008941)
9. Kumar P. PUVASOL induced bullous pemphigoid in a case of psoriasis. J Clin Diagn Res 2007;1:537-9.
10. Majmudar V, Herath D, O'Toole EA, Harrison A. Bullous pemphigoid of childhood: A rare disease with diagnostic and management challenges. Clin Exp Dermatol 2010;35:213-4
11. Nozu T, Mita H. Bullous pemphigoid and percutaneous endoscopic gastrostomy. Inter Med 2010;49:971-5.
12. Sheerin N, Bourke JF, Holder J, North J, Burns DA. Bullous pemphigoid following radiotherapy. Clin Exp Dermatol 1995;20:80-2.
13. Balato N, Ayala F, Patruno C, Turco P, Ruocco V. Bullous pemphigoid induced by a thermal burn. Int J Dermatol 1994;33:55-6. (Pubitemid 24044825)
14. Macfarlane AW, Verbov JL. Trauma-induced bullous pemphigoid. Clin Exp Dermatol 1989;14:245-9. (Pubitemid 19136938)
15. Kavak A, Parlak AH, Etinkaya R, Tzner T. Bullous pemphigoid on an incision scar of total knee prosthesis. Indian J Dermatol 2006;51:70-2. (Pubitemid 44271840)
16. Parslew R, Verbov JL. Bullous pemphigoid at sites of trauma. Br J Dermatol 1997;137:825-6.
17. Yeh SW, Ahmed B, Sami N, Razzaque Ahmed A. Blistering disorders: Diagnosis and treatment. Dermatol Ther 2003;16:214-23. (Pubitemid 37288679)
18. Tandon VR, Mahajan A, Sharma S. Tibolone induced bullous pemphigoid. JK Science 2008;10:26-7.
19. Ogawa H, Sakuma M, Morioka S Kitamura K, Sasai S, Imamura S, et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 1995;9:136-41.
20. Chorzelski TP, Jablonska S, Maciejowska E, Beutner EH, Wronskowski L. Coexistence of malignancies with bullous pemphigoid. Arch Dermatol 1978;114:964. (Pubitemid 9202423)
21. Cunha PR, Barraviera SR. Autoimmune bullous dermatoses. An Bras Dermatol 2009;84:111-24.
22. Satyapal S, Amladi S, Jerajani HR. Evaluation of salt split technique of immunofluorescence in bullous pemphigoid. Indian J Dermatol Venereol Leprol 2002;68:330-3.
23. Daneshpazhooh M, Shahdi M, Aghaeepoor M. A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases. Int J Dermatol 2004;43:348-51. (Pubitemid 38714595)
24. Zhou S, Wakelin SH, Allen J, Wojnarowska F. Blister fluid for the diagnosis of subepidermal immunobullous diseases: A comparative study of basement membrane zone autoantibodies detected in blister fluid and serum. Br J Dermatol 1998;139:27-32. (Pubitemid 28338060)
25. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231-5. (Pubitemid 16156221)
26. Atzori L, Deidda S, Aste N. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: Preliminary experience of the Dermatology Department of Cagliari. G Ital Dermatol Venereol 2008;143:1-8. (Pubitemid 351547719)
27. Chan YC, Sun YJ, Ng PP, Tan SH. Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid. Clin Exp Dermatol 2003;28:651-6. (Pubitemid 37430889)
28. Pfaltz K, Mertz K, Rose C, Scheidegger P, Pfaltz M, Kempf W. C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin. J Cutan Pathol 2010;37:654-8.
29. Chandler W, Zone J, Florell S. C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. J Cut Pathol 2009;36:655-9.
30. Morel P, Guillaume JC. Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day. A multicenter randomized study. Ann Dermatol Venereol 1984;111:925-8. (Pubitemid 15179493)
31. Sacchidanand S, Hiremath NC, Natraj HV, Revathi TN, Rani S, Pradeep G, et al. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore. Dermatol Online J 2003;9:2.
32. Beissert S, Werfel T, Frielin U. A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Bullous Pemphigoid. Arch Dermatol 2007;143:1536-42. (Pubitemid 350277770)
33. Burton JL, Harman RR, Peachey RD, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. Br Med J 1978;2:1190-1. (Pubitemid 9036094)
34. Kjellman P, Eriksson H, Berg P. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol 2008;144:612-6. (Pubitemid 351724421)
35. Grcan HM, Ahmed AR. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: Analysis of current data. Am J Clin Dermatol 2009;10:383-96.
36. Fivenson D, Breneman D, Rosen G, Hersh C, Cardone S, Mutasim D. Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 1994;130:753-8. (Pubitemid 24182685)
37. Bordignon M, Fortina AB, Pigozzi B. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009;219:357-8.
38. Roujeau JC, Guillaume JC, Morel P, Crickx B, Dalle E, Doutre MS, et al. Plasma exchange in bullous pemphigoid. Lancet 1984;2:486-8.
39. Ahmed AR. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001;45:825-35. (Pubitemid 33096620)
40. Dhar S. Intravenous immunoglobulin in dermatology. Indian J Dermatol 2009;54:77-9.
41. Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP. Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2010;10:CD002292.
42. Bernard P, Reguiai Z, Tancrde-Bohin E, Cordel N, Plantin P, Pauwels C, et al. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: A multicenter, prospective, cohort study. Arch Dermatol 2009;145:537-42.